Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)—A 20-year observational study

@inproceedings{Gant2019BodyWC,
  title={Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)—A 20-year observational study},
  author={Christina M Gant and Ijmke Mensink and S. Heleen Binnenmars and Job A M van der Palen and Stephan J L Bakker and Gerjan J. Navis and Gozewijn Dirk Laverman},
  booktitle={PloS one},
  year={2019}
}
BACKGROUND Although weight gain increases risk of type 2 diabetes, real-life data on the weight course in patients with established type 2 diabetes are scarce. We assessed weight course in a real-life diabetes secondary care setting and analyzed its association with patient characteristics, lifestyle habits and initiation of insulin, glucagon like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter-2 inhibitors (SGLT-2i). METHODS Data on weight, insulin, GLP-1 RA and SGLT… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Effects of exenatide twice daily , exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA 1 c � 10 . 0 % : Two pooled analyses including 20 randomised controlled trials

AC Jalving, CM Gant, +3 authors G Navis
  • Int J Clin Pract
  • 2017